Biomea Fusion Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell

19

BMEA
Biomea Fusion

Last Price:

$1.45

Seasonality Move:

2.93%

Sell

36

NBY
NovaBay Pharmaceuticals

Last Price:

$0.57

Seasonality Move:

-4.65%

Sell

19

Biomea Fusion (BMEA) is a Sell

Is Biomea Fusion a Buy, Sell or Hold?

The current Biomea Fusion [BMEA] share price is $1.44. The Score for BMEA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
BMEA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

36

NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

The current NovaBay Pharmaceuticals [NBY] share price is $0.55. The Score for NBY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMEA Stock Price Chart

What is Biomea Fusion's stock price today?

The Biomea Fusion share price today is $1.44

The current trend is relatively stagnant and BMEA is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

The NovaBay Pharmaceuticals share price today is $0.55

The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

BMEA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.16	Sell
Relative Strength Index (14 RSI):	39.7	Sell
Chaikin Money Flow:	-246905	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.42 - 2)	Sell
Bollinger Bands (100):	(1.74 - 3.72)	Sell

NBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.01	Sell
Relative Strength Index (14 RSI):	40.62	Sell
Chaikin Money Flow:	-7035	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.57 - 0.59)	Sell
Bollinger Bands (100):	(0.56 - 0.68)	Sell

BMEA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.46	Sell
20-day SMA:	1.6	Sell
50-day SMA:	1.9	Sell
200-day SMA:	5.23	Sell
8-day EMA:	1.47	Sell
20-day EMA:	1.59	Sell
50-day EMA:	2	Sell
200-day EMA:	4.83	Sell

NBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.56	Sell
20-day SMA:	0.57	Sell
50-day SMA:	0.57	Sell
200-day SMA:	0.61	Sell
8-day EMA:	0.56	Sell
20-day EMA:	0.57	Sell
50-day EMA:	0.58	Sell
200-day EMA:	2.02	Sell

Biomea Fusion Earnings Growth & BMEA Earnings Dates

Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.98 per share, and a decrease next year of $0.09 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.

Biomea Fusion Technical Analysis

	May 16	May 19	May 20	May 21	May 22	May 23	May 27	May 28	May 29	May 30
	May
	16	19	20	21	22	23	27	28	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

	May 16	May 19	May 20	May 21	May 22	May 23	May 27	May 28	May 29	May 30
	May
	16	19	20	21	22	23	27	28	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):